Dimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride

Catalog No. :
ACQPAZ183
CAS No. :
1666113-02-5
Molecular Formula :
C20H24ClNO4
Molecular Weight :
377.87

IUPAC Name:dimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride

Dimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$74.00Login to see priceInquiryInquiry
1g97%$382.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride
IUPAC Namedimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride
MDL No.MFCD28401007
Molecular FormulaC20H24ClNO4
Molecular Weight377.87
SMILESO=C(OC)CC1=CC=C(CNCC2=CC=C(CC(OC)=O)C=C2)C=C1.[H]Cl
InChI KeyUXWZVKZAHZTZLX-UHFFFAOYSA-N
SynonymDimethyl 2,2'-((azanediylbis(methylene))bis(4,1-phenylene))diacetate hydrochloride
CAS No.1666113-02-5
PubChem CID91667868

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACQPAZ183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTAMP063 route compound structure diagram
    ACTAMP06396524-70-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQPAZ183 route product structure diagram
    ACQPAZ1831666113-02-5
Inquiry

2. ACQPAZ183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWUBR197 route compound structure diagram
    ACWUBR1977398-42-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQPAZ183 route product structure diagram
    ACQPAZ1831666113-02-5
Inquiry

Comments (0)